Next Article in Journal / Special Issue
A Case of a Patient Who Successfully Achieved Early Wound Closure by Local Negative Pressure Wound Therapy (NPWT) against Compromised Wound Healing after Arterio-Venous Graft Infection
Previous Article in Journal
Welcome to the New Journal—Kidney and Dialysis
Review

iBTA-Induced Biotube® Blood Vessels: 2020 Update

1
Osaka Laboratory, Biotube Co., Ltd., Osaka 565-0842, Japan
2
Department of Cardiovascular Surgery, Yokohama General Hospital, Kanagawa 225-0025, Japan
3
Pre-Clinical Research Center, Institute of Development, Aging and Cancer, Tohoku University, Miyagi 980-8575, Japan
4
Department of Cardiovascular Surgery, Oita University Hospital, Oita 879-5593, Japan
5
Department of Mechanical Engineering, Faculty of Engineering Science, Kansai University, Osaka 564-8680, Japan
6
Department of Nephrology, Kameda Medical Center, Chiba 296-8602, Japan
7
Institute of Frontier Science and Technology, Okayama University of Science, Okayama 700-0005, Japan
8
Advanced Medical Engineering Research Center, Asahikawa Medical University, Hokkaido 078-8510, Japan
*
Author to whom correspondence should be addressed.
Academic Editors: Toshihide Naganuma, Yoshiaki Takemoto, Junji Uchida and Hideki Kawanishi
Kidney Dial. 2021, 1(1), 3-13; https://doi.org/10.3390/kidneydial1010002
Received: 12 April 2021 / Revised: 18 May 2021 / Accepted: 24 May 2021 / Published: 17 June 2021
(This article belongs to the Special Issue Dialysis Access - A New Era)
Blood access is a lifeline for dialysis patients. However, serious problems such as stenosis or obstruction of access blood vessels, which are life-threatening conditions in daily clinical practice, still remain. One of the most promising candidates for solving these problems may be Biotube blood vessels. More than 20 years have passed since the development of in-body tissue architecture (iBTA), a technology for preparing tissues for autologous implantation in patients. The tissues obtained by iBTA do not elicit immunological rejection, which is one of the ultimate goals of regenerative medical engineering; however, their practical applications were quite challenging. The seemingly unorthodox iBTA concepts that do not follow the current pre-established medical system may not be readily accepted in general medicine. In contrast, there are many diseases that cannot be adequately addressed even with the latest and most advanced medical technology. However, iBTA may be able to save patients with serious diseases. It is natural that the development of high-risk medical devices that do not fit the corporate logic would be avoided. In order to actively treat such largely unattached diseases, we started Biotube Co., Ltd. with an aim to contribute to society. Biotubes induced by iBTA are collagenous tubular tissues prepared in the patient’s body for autologous implantation. The application of Biotubes as tissues for vascular implantation has been studied for many years. Biotubes may have excellent potential as small-diameter artificial blood vessels, one of the most difficult to clinically achieve. Their possibility is currently being confirmed in preclinical tests. Biotubes may save hundreds of thousands of patients worldwide annually from amputation. In addition, we aim to eliminate the recuring access vascular problems in millions of dialysis patients. This study provides an update on the current development status and future possibilities of Biotubes and their preparation molds, Biotube Makers. View Full-Text
Keywords: biotube; tissue engineering; artificial blood vessel; regenerative medicine biotube; tissue engineering; artificial blood vessel; regenerative medicine
Show Figures

Figure 1

MDPI and ACS Style

Nakayama, Y.; Higashita, R.; Shiraishi, Y.; Umeno, T.; Tajikawa, T.; Yamada, A.; Mori, K.; Miyazaki, M.; Ohara, M.; Iwai, R.; Terazawa, T.; Oie, T.; Yambe, T.; Miyamoto, S. iBTA-Induced Biotube® Blood Vessels: 2020 Update. Kidney Dial. 2021, 1, 3-13. https://doi.org/10.3390/kidneydial1010002

AMA Style

Nakayama Y, Higashita R, Shiraishi Y, Umeno T, Tajikawa T, Yamada A, Mori K, Miyazaki M, Ohara M, Iwai R, Terazawa T, Oie T, Yambe T, Miyamoto S. iBTA-Induced Biotube® Blood Vessels: 2020 Update. Kidney and Dialysis. 2021; 1(1):3-13. https://doi.org/10.3390/kidneydial1010002

Chicago/Turabian Style

Nakayama, Yasuhide, Ryuji Higashita, Yasuyuki Shiraishi, Tadashi Umeno, Tsutomu Tajikawa, Akihiro Yamada, Kazuki Mori, Manami Miyazaki, Mamiko Ohara, Ryosuke Iwai, Takeshi Terazawa, Tomonori Oie, Tomoyuki Yambe, and Shinji Miyamoto. 2021. "iBTA-Induced Biotube® Blood Vessels: 2020 Update" Kidney and Dialysis 1, no. 1: 3-13. https://doi.org/10.3390/kidneydial1010002

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop